Evaluation of Nutritional, Inflammatory, and Fatty Acid Status in Patients with Gastric and Colorectal Cancer Receiving Chemotherapy

References

• Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO, Engstrom PF, Ezdinli EZ, et al. Prognostic effect of weight loss prior tochemotherapy in cancer patients. Am J Med. 1980;69(4):491–7. doi:10.1016/S0149-2918(05)80001-3
   PubMed Web of Science ®Google Scholar
• Andreyev HJN, Norman AR, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer. 1998;34(4):503–9. doi:10.1016/S0959-8049(97)10090-9
   PubMed Web of Science ®Google Scholar
• Gavazzi C, Colatruglio S, Sironi A, Mazzaferro V, Miceli R. Importance of early nutritional screening in patients with gastric cancer. Br J Nutr. 2011;106(12):1773–8. doi:10.1017/S0007114511002509
   PubMed Web of Science ®Google Scholar
• Buskermolen S, Langius JAE, Kruizenga HM, Ligthart-Melis GC, Heymans MW, Verheul HMW. Weight loss of 5% or more predicts loss of fat-free mass during palliative chemotherapy in patients with advanced cancer: a pilot study. Nutr Cancer. 2012;64(6):826–32. doi:10.1080/01635581.2012.690062
   PubMed Web of Science ®Google Scholar
• Deans DAC, Tan BH, Wigmore SJ, Ross JA, de Beaux AC, Paterson-Brown S, Fearon KCH. The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer. 2009;100(1):63–9. doi:10.1038/sj.bjc.6604828
   PubMed Web of Science ®Google Scholar
• Palesty JA, Dudrick SJ. What we have learned about cachexia in gastrointestinal cancer. Dig Dis. 2003;21(3):198–213. doi:10.1159/000073337
   PubMed Web of Science ®Google Scholar
• Tisdale MJ. Cachexia in cancer patients. Nat Rev Cancer. 2002;2(11):862–71. doi:10.1038/nrc927
   PubMed Web of Science ®Google Scholar
• Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. JCO. 2005;23(7):1431–8. doi:10.1200/JCO.2005.02.054
   PubMed Web of Science ®Google Scholar
• Paccagnella A, Morello M, Da Mosto MC, Baruffi C, Marcon ML, Gava A, Baggio V, Lamon S, Babare R, Rosti G, et al. Early nutritional intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing concurrent chemoradiotherapy. Support Care Cancer. 2010;18(7):837–45. doi:10.1007/s00520-009-0717-0
   PubMed Web of Science ®Google Scholar
• Argilés JM, Busquets S, López-Soriano FJ. The pivotal role of cytokines in muscle wasting during cancer. Int J Biochem Cell Biol. 2005;37(8):1609–19. doi:10.1016/j.biocel.2005.03.007
   PubMed Web of Science ®Google Scholar
• Stephens NA, Skipworth RJE. Fearon KCH: cachexia, survival and the acute phase response. Curr Opin Support Palliat Care. 2008;2:267–74.
   PubMedGoogle Scholar
• Barber MD, Fearon KCH, Ross JA. Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer. Clin Sci. 1999;96(1):83–7. doi:10.1042/CS19980185
   PubMed Web of Science ®Google Scholar
• Richards CH, Roxburgh CSD, MacMillan MT, Isswiasi S, Robertson EG, Guthrie GK, Horgan PG, McMillan DC. The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer. PLoS ONE. 2012;7(8):e41883. doi:10.1371/journal.pone.0041883
   PubMed Web of Science ®Google Scholar
• Gomes de Lima KV, Maio R. Nutritional status, systemic inflammation and prognosis of patients with gastrointestinal cancer. Nutr Hosp. 2012;27:707–14.
   PubMed Web of Science ®Google Scholar
• Maurício SF, da Silva JB, Bering T, Correia MI. Relationship between nutritional status and the Glasgow Prognostic Score in patients with colorectal cancer. Nutrition. 2013;29(4):625–9. doi:10.1016/j.nut.2012.09.016
   PubMed Web of Science ®Google Scholar
• McMillan DC, Scott HR, Watson WS, Preston T, Milroy R, McArdle CS. Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients. Nutr Cancer. 1998;31(2):101–5. doi:10.1080/01635589809514687
   PubMed Web of Science ®Google Scholar
• O'Gorman P, McMillan DC, McArdle CS. Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer. Nutr Cancer. 1999;35(2):127–9. doi:10.1207/S15327914NC352_5
   PubMed Web of Science ®Google Scholar
• Calder PC: n- 3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83:S1505–1519S.
   PubMed Web of Science ®Google Scholar
• Calder PC. N- 3 Polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids. 2003;38(4):343–52. doi:10.1007/s11745-003-1068-y
   PubMed Web of Science ®Google Scholar
• Serhan CN, Petasis NA. Resolvins and protectins in inflammation resolution. Chem Rev. 2011;111(10):5922–43. doi:10.1021/cr100396c
   PubMed Web of Science ®Google Scholar
• Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Omega-3 fatty acids and inflammation. Br J Clin Pharmacol. 2013;75(3):645–62. doi:10.1111/j.1365-2125.2012.04374.x
   PubMed Web of Science ®Google Scholar
• Buckley CD, Gilroy DW, Serhan CN. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity. 2014;40(3):315–27. doi:10.1016/j.immuni.2014.02.009
   PubMed Web of Science ®Google Scholar
• Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary long-chain n- 3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr. 2004;79(6):935–45. doi:10.1093/ajcn/79.6.935
   PubMed Web of Science ®Google Scholar
• Macášek J, Vecka M, Žák A, Urbánek M, Krechler T, Petruželka L, Staňková B, Zeman M. Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters. Nutr Cancer. 2012;64(7):946–55. doi:10.1080/01635581.2012.716138
   PubMed Web of Science ®Google Scholar
• McClinton S, Moffat LE, Horrobin DF, Manku MS. Abnormalities of essential fatty acid distribution in the plasma phospholipids of patients with bladder cancer. Br J Cancer. 1991;63(2):314–6. doi:10.1038/bjc.1991.73
   PubMed Web of Science ®Google Scholar
• Pratt VC, Watanabe S, Bruera E, Mackey J, Clandinin MT, Baracos VE, Field CJ. Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation. Br J Cancer. 2002;87(12):1370–8. doi:10.1038/sj.bjc.6600659
   PubMed Web of Science ®Google Scholar
• Zuijdgeest-Van Leeuwen SD, Van der Heijden MS, Rietveld T, Van den Berg JWO, Tilanus HW, Burgers JA, Paul Wilson JH, Dagnelie PC. Fatty acid composition of plasma lipids in patients with pancreatic, lung and oesophageal cancer in comparison with healthy subjects. Clin Nutr. 2002;21(3):225–30. doi:10.1054/clnu.2001.0530
   PubMed Web of Science ®Google Scholar
• Baró L, Hermoso JC, Núñez MC, Jiménez-Rios JA, Gil A. Abnormalities in plasma and red blood cell fatty acid profiles of patients with colorectal cancer. Br J Cancer. 1998;77(11):1978–83. doi:10.1038/bjc.1998.328
   PubMed Web of Science ®Google Scholar
• Mosconi C, Agradi E, Gambetta A, Bozzetti F, Galli C. Decrease of polyunsaturated fatty acids and elevation of the oleic/stearic acid ratio in plasma and red blood cell lipids of malnourished cancer patients. JPEN J Parenter Enteral Nutr. 1989;13(5):501–4. doi:10.1177/0148607189013005501
   PubMed Web of Science ®Google Scholar
• Durnin J, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr. 1974;32(01):77–97. doi:10.1079/BJN19740060
   PubMed Web of Science ®Google Scholar
• Lukaski HC, Bolonchuk WW, Hall CB, Siders WA. Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol. 1986;60(4):1327–32. doi:10.1152/jappl.1986.60.4.1327
   PubMed Web of Science ®Google Scholar
• Kotler DP, Burastero S, Wang J, Pierson RN. Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: effects of race, sex, and disease. Am J Clin Nutr. 1996;64(3):489S–97S. doi:10.1093/ajcn/64.3.489S
   PubMed Web of Science ®Google Scholar
• Heymsfield SB, McManus C, Smith J, Stevens V, Nixon DW. Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area. Am J Clin Nutr. 1982;36(4):680–90. doi:10.1093/ajcn/36.4.680
   PubMed Web of Science ®Google Scholar
• Frisancho AR. Anthropometric standards for the assessment of growth and nutritional status. Ann Arbor, MI: University of Michigan Press, 1990.
   Google Scholar
• Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226(1):497–509.
   PubMed Web of Science ®Google Scholar
• Nishi S, Kendall CWC, Gascoyne A-M, Bazinet RP, Bashyam B, Lapsley KG, Augustin LSA, Sievenpiper JL, Jenkins DJA. Effect of almond consumption on the serum fatty acid profile: a dose–response study. Br J Nutr. 2014;112(7):1137–46. doi:10.1017/S0007114514001640
   PubMed Web of Science ®Google Scholar
• Xie F-l, Wang Y-q, Peng L-f, Lin F-y, He Y-l, Jiang Z-q. Beneficial effect of educational and nutritional intervention on the nutritional status and compliance of gastric cancer patients undergoing chemotherapy: a randomized trial. Nutr Cancer. 2017;69(5):762–71. doi:10.1080/01635581.2017.1321131
   PubMed Web of Science ®Google Scholar
• Prado CM, Sawyer MB, Ghosh S, Lieffers JR, Esfandiari N, Antoun S, Baracos VE. Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?. Am J Clin Nutr. 2013;98(4):1012–9. doi:10.3945/ajcn.113.060228
   PubMed Web of Science ®Google Scholar
• McMillan DC, Elahi MM, Sattar N, Angerson WJ, Johnstone J, McArdle CS. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer. 2001;41(1-2):64–9. doi:10.1207/S15327914NC41-1&2_8
   PubMed Web of Science ®Google Scholar
• Cvetković Z, Vučić V, Cvetković B, Karadžić I, Ranić M, Glibetić M. Distribution of plasma fatty acids is associated with response to chemotherapy in non-Hodgkin’s lymphoma patients. Med Oncol. 2013;30(4):741. doi:10.1007/s12032-013-0741-2
   PubMed Web of Science ®Google Scholar
• Murphy RA, Bureyko TF, Mourtzakis M, Chu QS, Clandinin MT, Reiman T, Mazurak VC. Aberrations in plasma phospholipid fatty acids in lung cancer patients. Lipids. 2012;47(4):363–9. doi:10.1007/s11745-011-3641-2
   PubMed Web of Science ®Google Scholar
• Currie E, Schulze A, Zechner R, Walther TC, Farese RV. Cellular fatty acid metabolism and cancer. Cell Metab. 2013;18(2):153–61. doi:10.1016/j.cmet.2013.05.017
   PubMed Web of Science ®Google Scholar
• Read JA, Beale PJ, Volker DH, Smith N, Childs A, Clarke SJ. Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. Support Care Cancer. 2007;15(3):301–7. doi:10.1007/s00520-006-0153-3
   PubMed Web of Science ®Google Scholar
• Barber MD, Ross JA, Preston T, Shenkin A, Fearon K. Fish oil–enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer. J Nutr. 1999;129(6):1120–5. doi:10.1093/jn/129.6.1120
   PubMed Web of Science ®Google Scholar
• Wigmore SJ, Barber MD, Ross JA, Tisdale MJ, Fearon KCH. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer. 2000;36(2):177–84. doi:10.1207/S15327914NC3602_6
   PubMed Web of Science ®Google Scholar
• Guthrie GJK, Roxburgh CSD, Richards CH, Horgan PG, McMillan DC. Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer. Br J Cancer. 2013;109(1):131–7. doi:10.1038/bjc.2013.291
   PubMed Web of Science ®Google Scholar
• Miura T, Mitsunaga S, Ikeda M, Shimizu S, Ohno I. Characterization of patients with advanced pancreatic cancer and high serum interleukin-6 levels. Pancreas. 2015;44:756–63.
   PubMed Web of Science ®Google Scholar
• Ikeguchi M, Hatada T, Yamamoto M, Miyake T, Matsunaga T, Fukumoto Y, Yamada Y, Fukuda K, Saito H, Tatebe S, et al. Serum interleukin-6 and -10 levels in patients with gastric cancer. Gastric Cancer. 2009;12(2):95–100. : doi:10.1007/s10120-009-0509-8
   PubMed Web of Science ®Google Scholar
• Mouawad R, Benhammouda A, Rixe O, Antoine EC, Borel C, Weil M, Khayat D, Soubrane C. Endogenous interleukin 6 levels in patients with metastatic malignant melanoma: correlation with tumor burden. Clin. Cancer Res. 1996;2(8):1405–9.
   PubMed Web of Science ®Google Scholar
• Mourtzakis M, Prado CMM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33(5):997–1006. doi:10.1139/H08-075
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883–99. doi:10.1016/j.cell.2010.01.025
   PubMed Web of Science ®Google Scholar
• Mocellin MC, Camargo CQ, Nunes EA, Fiates GMR, Trindade E. A systematic review and meta-analysis of the n-3 polyunsaturated fatty acids effects on inflammatory markers in colorectal cancer. Clin Nutr. 2016;35(2):359–69. doi:10.1016/j.clnu.2015.04.013
   PubMed Web of Science ®Google Scholar
• Galli C, Calder PC. Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review. Ann Nutr Metab. 2009;55(1-3):123–39. doi:10.1159/000228999
   PubMed Web of Science ®Google Scholar
• Meydani SN, Dinarello CA. Influence of dietary fatty acids on cytokine production and its clinical implications. Nutr Clin Pract. 1993;8(2):65–72. doi:10.1177/011542659300800265
   PubMedGoogle Scholar
• Silva J. d A P, Trindade E. B S d M, Fabre M. E d S, Menegotto VM, Gevaerd S, Buss Z. d S, Frode TS. Fish oil supplement alters markers of inflammatory and nutritional status in colorectal cancer patients. Nutr Cancer. 2012;64(2):267–73. doi:10.1080/01635581.2012.643133
   PubMed Web of Science ®Google Scholar
• Wigmore SJ, Ross JA, Stuart Falconer J, Plester CE, Tisdale MJ, Carter DC, Ch Fearon K. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition. 1996;12(1):S27–S30. doi:10.1016/0899-9007(96)90014-3
   PubMed Web of Science ®Google Scholar
• Stene GB, Helbostad JL, Amundsen T, Sørhaug S, Hjelde H, Kaasa S, Grønberg BH. Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer. Acta Oncol. 2015;54(3):340–8. doi:10.3109/0284186X.2014.953259
   PubMed Web of Science ®Google Scholar
• Kushner RF, Gudivaka R, Schoeller DA. Clinical characteristics influencing bioelectrical impedance analysis measurements. Am J Clin Nutr. 1996;64:432S–7S.
   Web of Science ®Google Scholar